Martin Shkreli arrested — it’s a Christmas miracle!

We are now at T-minus 8 days until Christmas.

You know, I really have no idea why the term “T-minus” is used for countdowns. Could this be easily solved by searching it on Wikipedia? Yes. Will I actually do that? No.

Choosing what you want to receive as a gift for the holidays gets more difficult with each passing year. As a kid, you wanted the latest new toys that recently hit the market.

As a teenager, you just want cash so you can buy more drugs and alcohol. Erm, I didn’t mean that. What I meant to say was…  uhh, alcohol and drugs. Smooth save there.

But when you’re a young adult, and you have a stable job, then you almost feel guilty asking for stuff when you can afford it yourself.

Martin ShkreliAt the same time, since its customary for your close friends and family to give you a gift, you have to come up with something.

For many people, Christmas came early on Thursday. Don’t get confused by that though. Christmas is still the 25th. It’s just a metaphor.

But I say that in light of the news that pharmaceuticals bad boy, Martin Shkreli, was arrested on securities fraud charges.

You all remember Shkreli. Besides Donald Trump, he’s probably the most hated man in America, if not more so. He’s the one who bought a drug that treats a rare parasitic condition sometimes found in babies or HIV patients, and then jacked its price from $13.50 per pill to $750.

The intense backlash he faced made him change his mind, but then he reversed course again. Just this month, when asked what he would have done differently, he said he would have “raised the price higher.”

Shkreli also is the guy who purchased the lone copy of the recently released Wu Tang Clan album for $2 million.

And he also happens to have the most punchable face in America.

Nonetheless, Shkreli was arrested for his alleged scheme in using a company’s assets that he was CEO of to pay back people he owed, which apparently is illegal. I’m not going to pretend I know all the details.

Even his “being hauled away by FBI agents while under arrest” look is annoying. He looks like an emo Eminem.

But seriously, I didn’t really feel like I’ve been overcome with Christmas spirit until today. It’s like the end of the holiday movie, where the greedy businessman and antagonist of the film goes down. I feel like we should be celebrating this arrest in Jimmy Stewart’s living room.

Also adding to the holiday atmosphere today was the release of a teaser Fuller Housetrailer for the upcoming Fuller House, the Netflix continuation of the classic original series that is set to premiere in late February.

It was a teaser in every sense of the word, as the only glimpses we get of the characters are their voices, from behind a closed door inside the house where the older series took place.

There are undoubtedly some things that should be left in the past. We love seeing our favorite shows come back, but sometimes it’s done simply for commercial reasons, and the sequel ends up lacking substance.

That being said, I think Fuller House will succeed. Many of the actors managed to stay relevant over the years, and with the right team of writers, I believe the show can accommodate to the current times. Plus it’s on NetFlix, and nothing in the world has ever failed on NetFlix.

Hey, you know what else just became a fuller house?


Because Martin Shkreli is there.

A glimpse into the controversial world of pharmaceutical drug price gouging

Internet users reacted strongly today when they were made aware of a common business technique among pharmaceutical companies — often chided as price gouging — in which they drastically raise the cost of a specialty drug used fight severe infections or diseases, in order to make a profit.

The company in question that stirred people’s emotions is New York-based Turing Pharmaceuticals, which purchased a drug called Daraprim last August, and raised its price from $13.50 a tablet to $750 overnight — a 5,000 percent increase.

The drug is the standard form of treatment against toxoplosmosis, a life-threatening parasite infection that can especially harm people with compromised immune systems, like those with HIV, cancer, or even pregnant women.

DrugsNow, it’s so incredibly easy to point blame at this company — and especially its CEO, Martin Shkreli, who has a face and certain aura about him that just asks to be hated — but the truth of the matter is that this is a problem that has been going on for a long time.

Specialty drugs that treat serious conditions can cost tens of thousands of dollars per year. Meaning even those with good insurance will still have to dig deep into their wallets to get the medicine they need.

My biggest question is why this is even allowed to happen. It’s the pure essence of price gouging — a company, owning a drug that is the only one that can fight a specific disease, and facing no competition, prices it however they please, knowing that people have no choice but to buy it.

Companies justify their tactics by saying they give away their drugs at a discounted cost to the neediest of people, and that they plan to use their profits to invest in increasing education and research for the disease their drug fights, and even try to create a better antidote.

To his credit, Shkreli went on CNBC on Monday to explain his motives for raising the price of Daraprim.

People need a face to physically hate when they hear about a problem, or else it doesn’t resonate. Shkreli is that man for today. The same thing happened this summer when a Minneapolis dentist killed a well-known lion in Zimbabwe. The TPproblem was big-game hunting, not the dentist, whose name no one even remembers anymore. (It’s Walter Palmer, who also has a very punchable face.)

The actions of Turing Pharmaceuticals prompted Hillary Clinton to outline a plan to stop pharmaceutical price gouging. Bernie Sanders has also been on top of the issue.

The bottom line is sick people are being financially burdened because these companies are given free rein to run wild, facing little regulations when determining pricing for their drugs. It’s hard to blame people like Shkreli for taking advantage of a flawed system.

Shkreli reportedly backed down by the way, telling NBC News Tuesday evening that the public outrage will make his company reassess its price hike.

Nothing interests people more than a classic tale of good versus evil. In this case, it’s corporate greed against the weak and the sickly. It’s the biggest David versus Goliath story since Harry Potter defeated Voldemort in the Battle of Hogwarts.

And now it’s time politicians to step up, be useful for once, and Dumbledore the shit out of this problem.